596 related articles for article (PubMed ID: 11230394)
1. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
[TBL] [Abstract][Full Text] [Related]
2. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions.
Sreenivas G; Ansari NA; Kataria J; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1777-8. PubMed ID: 15071047
[TBL] [Abstract][Full Text] [Related]
3. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P
Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
[TBL] [Abstract][Full Text] [Related]
4. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
5. An epitope-specific PCR test for diagnosis of Leishmania donovani infections.
Arora SK; Gupta S; Bhardwaj S; Sachdeva N; Sharma NL
Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):41-5. PubMed ID: 17888473
[TBL] [Abstract][Full Text] [Related]
6. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
7. Sequencing a specific kinetoplast DNA fragment of Leishmania donovani for polymerase chain reaction amplification in diagnosis of leishmaniasis in bone marrow and blood samples.
Hu XS; Yang WT; Lu HG; Yan HP; Cheng JP; Ma Y; Jin BQ; Zhang T
J Parasitol; 2000 Aug; 86(4):822-6. PubMed ID: 10958464
[TBL] [Abstract][Full Text] [Related]
8. PCR diagnosis of visceral leishmaniasis in an endemic region, Mymensingh district, Bangladesh.
Alam MZ; Shamsuzzaman AK; Kuhls K; Schönian G
Trop Med Int Health; 2009 May; 14(5):499-503. PubMed ID: 19222820
[TBL] [Abstract][Full Text] [Related]
9. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
[TBL] [Abstract][Full Text] [Related]
10. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
Dey A; Singh S
Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
[TBL] [Abstract][Full Text] [Related]
11. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
[TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood.
Pal S; Aggarwal G; Haldar A; Majumdar A; Majumdar HK; Duttagupta S
Med Sci Monit; 2004 Jan; 10(1):MT1-5. PubMed ID: 14704640
[TBL] [Abstract][Full Text] [Related]
14. Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
Verma S; Avishek K; Sharma V; Negi NS; Ramesh V; Salotra P
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):390-5. PubMed ID: 23433714
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
16. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
[TBL] [Abstract][Full Text] [Related]
17. RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.
Khanra S; Datta S; Mondal D; Saha P; Bandopadhyay SK; Roy S; Manna M
Acta Trop; 2012 Dec; 124(3):229-34. PubMed ID: 22960646
[TBL] [Abstract][Full Text] [Related]
18. Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods.
Salotra P; Sreenivas G; Beena KR; Mukherjee A; Ramesh V
J Clin Pathol; 2003 Nov; 56(11):840-3. PubMed ID: 14600129
[TBL] [Abstract][Full Text] [Related]
19. Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection.
Verma S; Singh R; Sharma V; Bumb RA; Negi NS; Ramesh V; Salotra P
BMC Infect Dis; 2017 Mar; 17(1):223. PubMed ID: 28335752
[TBL] [Abstract][Full Text] [Related]
20. Antimony susceptible
Ghosh S; Verma A; Kumar D; Deep DK; Ramesh V; Salotra P; Singh R
Microbiol Spectr; 2024 Jun; 12(6):e0402623. PubMed ID: 38712926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
